Vikash Reebye

MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

Debashis Sarker, Ruth Plummer, Tim Meyer et al. · Clinical Cancer Research · 2020 · 156 citations · Full text

Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo

Vikash Reebye, Pål Sætrom, Paul J. Mintz et al. · Hepatology · 2013 · 119 citations · Full text

Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer

Jon Voutila, Vikash Reebye, Thomas C. Roberts et al. · Molecular Therapy · 2017 · 118 citations · Full text

Prohibitin, a protein downregulated by androgens, represses androgen receptor activity

Simon C. Gamble, Deepa Chotai, Michael Odontiadis et al. · Oncogene · 2006 · 92 citations

Androgen Receptor Activity, Signal Transduction, Endocrine Mechanism +9

Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer

Vikash Reebye, Kai‐Wen Huang, Vivian Lin et al. · Oncogene · 2018 · 92 citations · Full text

Tumor Biology, Gene Activation, Preclinical Studies +21